Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
GigaMune
San Francisco, California, United Statesgigamune.com ↗
- Ownership
- Private
- Employees
- ~25
- Development stage
- Other
01
Overview
GigaMune develops in vivo gene therapies that deliver engineered T cell receptors or chimeric antigen receptors directly into patients using viral vectors. This approach aims to bypass the complex manufacturing bottlenecks of traditional ex vivo cell therapies like CAR-T. The company’s pipeline focuses on cancer indications such as multiple myeloma, AML, solid tumors with shared TAAs or driver mutations, and inherited blood disorders like sickle cell disease. No clinical results have been published; programs remain at the preclinical/IND-enabling stage.
- Therapeutic areas
- HematologyImmunologyOncology
- Modalities
- Gene therapyCAR-T cell therapyTCR-T cell therapyViral vector-based gene deliveryAntibody fragment (for targeting)Artificial intelligence-driven discovery (enabling technology)
- Industry
- Biotech
02
Partnerships
Massachusetts General Hospital & Harvard Medical School (strategic research partnership)
Beyond the preview
Go deeper on GigaMune.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on GigaMune.